UroGen Pharma Reports Third Quarter 2023 Financial Results

Go back to UroGen Pharma Reports Third Quarter 2023 Financial Results
(NASDAQ: URGN) Delayed: 34.04 -0.45 (1.3%)
Previous Close $34.49    52 Week High $ 
Open $34.64    52 Week Low $ 
Day High $35.00    P/E N/A 
Day Low $33.87    EPS $ 
Volume 670,047